secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001193125-23-232464
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA receives $4.9M commercial payment from Genentech for VABYSMO H1 2023 sales
-------------------------------------------------------------------------------

- Received $4.9 million from Genentech (Roche) for VABYSMO net sales in first six months of 2023.
- Payment reflects 0.5% royalty stream on VABYSMO sales in certain regions for ten years from first commercial sale.
- XOMA acquired this royalty interest through an October 2021 purchase agreement with Affitech Research AS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312523232464/0001193125-23-232464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312523232464/d348732d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-232464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer